A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever

Vaccine

Volumn 29, Issue 46, 2011, Pages 8364-8372

  Sun, Yuan ^a   Li, Hong Yu ^a   Tian, Da Yong ^a   Han, Qiu Ying ^a   Zhang, Xin ^a   Li, Na ^a   Qiu, Hua Ji ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Alphavirus replicon; Chimeric vector; Classical swine fever; Recombinant adenovirus; Sterile immunity; Vaccine

Indexed keywords

ADENOVIRUS VECTOR; ADENOVIRUS VECTORED VACCINE; ALPHAVIRUS REPLICON VECTORED VACCINE; CHIMERIC VECTOR BASED VACCINE; GLYCOPROTEIN E2; LIVE VACCINE; PESTIVIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS VACCINE;

ADENOVIRUS; ALPHA VIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; CLASSICAL SWINE FEVER; COMPARATIVE STUDY; CONTROLLED STUDY; EXPERIMENTAL PIG; EXPERIMENTAL RABBIT; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; NONHUMAN; PESTIVIRUS; PRIORITY JOURNAL; REPLICON; STERILE IMMUNITY; VIRAL GENE DELIVERY SYSTEM; VIRUS RECOMBINANT; VIRUS STRAIN;

ADENOVIRIDAE; ALPHAVIRUS; ANIMALS; ANTIBODIES, VIRAL; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; GENETIC VECTORS; IMMUNITY, CELLULAR; RABBITS; SURVIVAL ANALYSIS; SWINE; VACCINATION; VACCINES, DNA; VACCINES, SYNTHETIC; VIRAL PROTEINS; VIRAL VACCINES;

EID: 80053937616     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.08.085     Document Type: Article

References (44)

1. van Regenmortel M.H.V., Fauquet C.M., Bishop D.H.L., Carstens E.B., Estes M.K., Lemon S.M., et al. Virus taxonomy. Seventh report of the international committee on taxonomy of viruses 2000, Academic Press. 1st ed.
2. Rice C.M. Flaviviridae: the viruses and their replication. Fundamental virology 1996, 931-959. Lippincott Raven, Philadelphia. third ed. D.M. Knipe, P.M. Howley (Eds.).
3. van Gennip H.G.P., van Rijn P.A., Widjojoatmodjo M.N., de Smit A.J., Moormann R.J.M. Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response. Vaccine 2000, 19:447-459.
4. Weiland E., Stark R., Haas B., Rumenapf T., Meyers G., Thiel H.J. Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disulfide-linked heterodimer. J Virol 1990, 64:3563-3569.
5. van Oirschot J.T. Vaccinology of classical swine fever: from lab to field. Vet Microbiol 2003, 96:367-384.
6. Kobinger G.P., Weiner D.J., Yu Q.C., Wilson J.M. Filoviruspseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat Biotechnol 2001, 19(3):225-230.
7. Rayner J.O., Dryga S.A., Kamrud K.I. Alphavirus vectors and vaccination. Rev Med Virol 2002, 12:279-296.
8. Lauterbach H., Ried C., Epstein A.L., Marconi P., Brocker T. Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity. J Gen Virol 2005, 86:2401-2410.
9. Jathoul A.P., Holley J.L., Garmory H.S. Efficacy DNA vaccines expressing the type F botulinum toxin Hc fragment using different promoters. Vaccine 2004, 2:3942-3946.
10. Berglund P., Semerdou C., Fleeton M.N., Tubulekas I., Liljestrom P. Enhancing immune responses using suicidal DNA vaccines. Nat Biotechnol 1998, 16:562-565.
11. Watanabe T., Watanabe S., Neumann G., Kida H., Kawaoka Y. Immunogenicity and protective efficacy of replication-incompetent influenza virus-like particles. J Virol 2002, 76:767-773.
12. Fitzgerald J.C., Gao G.P., Reyes-Sandoval A., Pavlakis G.N., Xiang Z.Q., Wlazlo A.P., et al. A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag. J Immunol 2003, 170(3):1416-1422.
13. Schnell M.A., Zhang Y., Tazelaar J., Gao G.P., Yu Q.C., Qian R., et al. Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol Ther 2001, 3(5 (Pt. 1)):708-722.
14. Wu L., Kong W.P., Nabel G.J. Enhanced breadth of CD4 T-cell immunity by DNA prime and adenovirus boost immunization to human immunodeficiency virus Env and Gag immunogens. J Virol 2005, 79(13):8024-8031.
15. Yang Y., Greenough K., Wilson J.M. Transient immune blockade prevents formation of neutralizing antibody to recombinant adenovirus and allows repeated gene transfer to mouse liver. Gene Ther 1996, 3(5):412-420.
16. Fischer L., Tronel J.P., Pardo-David C., Tanner P., Colombet G., Minke J., et al. Vaccination of puppies born to immune dams with a canine adenovirus-based vaccine protects against a canine distemper virus challenge. Vaccine 2002, 20:3485-3497.
17. Sun Y., Liu D.F., Wang Y.F., Liang B.B., Cheng D., Li N., et al. Generation and efficacy evaluation of a recombinant adenovirus expressing the E2 protein of classical swine fever virus. Res Vet Sci 2010, 88:77-82.
18. Li N., Qiu H.J., Zhao J.J., Li Y., Wang M.J., Lu B.W., et al. A Semliki Forest virus replicon vectored DNA vaccine expressing the E2 glycoprotein of classical swine fever virus protects pigs from lethal challenge. Vaccine 2007, 25(15):2907-2912.
19. Li N., Zhao J.J., Zhao H.P., Sun Y., Zhu Q.H., Tong G.Z., et al. Protection of pigs from lethal challenge by a DNA vaccine based on an alphavirus replicon expressing the E2 glycoprotein of classical swine fever virus. J Virol Methods 2007, 144:73-78.
20. Perri S., Greer C.E., Thudium K., Doe B., Legg H., Liu H. An alphavirus replicon particle chimera derived from Venezuelan equine encephalitis and Sindbis viruses is a potent gene-based vaccine delivery vector. J Virol 2003, 77:10394-10403.
21. Peng W.P., Hou Q., Xia Z.H., Chen D., Li N., Sun Y., et al. Identification of a conserved linear B-cell epitope at the N-terminus of the E2 glycoprotein of Classical swine fever virus by phage-displayed random peptide library. Virus Res 2008, 135:267-272.
22. Zhao J.J., Cheng D., Li N., Sun Y., Shi Z., Zhu Q.H., et al. Evaluation of a multiplex real-time RT-PCR for quantitative and differential detection of wild-type viruses and C-strain vaccine of classical swine fever. Vet Microbiol 2008, 126:1-10.
23. Sánchez-Cordón P.J., Rodríguez-Sánchez B., Risalde M.A., Molina V., Pedrera M., Sánchez-Vizcaíno J.M., et al. Immunohistochemical detection of bluetongue virus in fixed tissue. J Comp Pathol 2010, 143:20-28.
24. Buonavoglia C., Falcone E., Pestalozza S., Di Trani L., D'Amore E. A rapid serum neutralization test in microplates for the detection of antibodies to hog cholera virus. J Virol Methods 1989, 23:77-79.
25. Bruna-Romero O., Gonzalez-Aseguinolaza G., Hafalla J.C., Tsuji M., Nussenzweig R.S. Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen. Proc Natl Acad Sci USA 2001, 98:11491-11496.
26. Johnson P.R., Schnepp B.C., Connell M.J., Rohne D., Robinson S., Krivulka G.R., et al. Novel adeno-associated virus vector vaccine restricts replication of simian immunodeficiency virus in macaques. J Virol 2005, 79:955-965.
27. Lai C.M., Lai Y.K., Rakoczy P.E. Adenovirus and adeno-associated virus vectors. DNA Cell Biol 2002, 21:895-913.
28. van Rijn P.A, Bossers A., Wensvoort G., Moormann R.J. Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge. J Gen Virol 1996, 77(11):2737-2745.
29. Bouma A., De Smit A.J., De Kluijver E.P., Terpstra C., Moormann R.J. Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus. Vet Microbiol 1999, 66(2):101-114.
30. Bouma A., De Smit A.J., De Jong M.C., De Kluijver E.P., Moormann R.J. Determination of the onset of the herd-immunity induced by the E2 sub-unit vaccine against classical swine fever virus. Vaccine 2000, 18:1374-1381.
31. Hammond J.M., McCoy R.J., Jansen E.S., Morrissy C.J., Hodgson A.L., Johnson M.A. Vaccination with a single dose of a recombinant porcine adenovirus expressing the classical swine fever virus gp55 (E2) gene protects pigs against classical swine fever. Vaccine 2000, 18:1040-1050.
32. Schlesinger S., Dubensky T.W. Alphavirus vectors for gene expression and vaccines. Curr Opin Biotechnol 1999, 10:434-439.
33. Nordström E.K., Forsell M.N., Barnfieid C., Bonin E., Hanke T., Sundström M., et al. Enhanced immunogenicity using an alphavirus replicon DNA vaccine against human immunodeficiency virus type 1. J Gen Virol 2005, 86(2):349-354.
34. Saiku K.U., Lee J.S., Kissner T.L., Dyas B., Ulrich R.G. Toll-like receptor and cytokine expression patterns of CD56+ T cells are similar to natural killer cells in response to infection with Venezuelan equine encephalitis virus replicons. J Infect Dis 2003, 188:1562-1570.
35. Hooper J.W., Golden J.W., Ferro A.M., King A.D. Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge. Vaccine 2007, 25:1814-1823.
36. Morelli A.E., Larregina A.T., Ganster R.W., Zahorchak A.F., Plowey J.M., Takayama T., et al. Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway. J Virol 2000, 74:9617-9628.
37. Rea D., Schagen F.H., Hoeben R.C., Mehtali M., Havenga M.J., Toes R.E., et al. Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset. J Virol 1999, 73(12):10245-10253.
38. Tan Y., Hackett N.R., Boyer J.L., Crystal R.G. Protective immunity evoked against anthrax lethal toxin after a single intramuscular administration of an adenovirus-based vaccine encoding humanized protective antigen. Hum Gene Ther 2003, 14:1673-1682.
39. Tatsis N., Ertl H.C. Adenoviruses as vaccine vectors. Mol Ther 2004, 10:616-629.
40. Wesley R.D., Tang M., Lager K.M. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus. Vaccine 2004, 22:3427-3434.
41. Gonin P., Oualikene W., Fournier A., Eloit M. Comparison of the efficacy of replication-defective adenovirus and Nyvac poxvirus as vaccine vectors in mice. Vaccine 1996, 14:1083-1087.
42. Lindsay R.W., Darrah P.A., Quinn K.M., Wille-Reece U., Mattei L.M., Iwasaki A., et al. CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling. J Immunol 2010, 185(3):1513-1521.
43. Yamaguchi T., Kawabata K., Koizumi N., Sakurai F., Nakashima K., Sakurai H., et al. Role of MyD88 and TLR9 in the innate immune response elicited by serotype 5 adenoviral vectors. Hum Gene Ther 2007, 18(8):753-762.
44. van Oirschot J.T. Vaccinology of classical swine fever: from lab to field. Vet Microbiol 2003, 96(4):367-384.